Cayman Chemical SM-102 amino lipid

Tuesday, 05 September, 2023 | Supplied by: Sapphire Bioscience

SM-102 is an ionisable cationic amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Administration of luciferase mRNA in SM-102-containing LNPs induces hepatic luciferase expression in mice. Formulations containing SM-102 have been used in the development of LNPs for delivery of mRNA-based vaccines.

Cayman Chemical’s SM-102 is distributed in Australia and New Zealand by Sapphire Bioscience.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022

Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)

Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...

Echelon Biosciences ionisable lipids

Echelon Biosciences' ionisable lipids are the key components of lipid nanoparticles (LNPs)...

BioStatus CyTRAK Orange fluorescent dye

BioStatus's CyTRAK Orange is a novel fluorescent dye that preferentially stains the nucleus...

Content from other channels on our network

A sustainable approach to increase wastewater recycling

City of Gosnells develops tree production nursery

Experts warn against health risks of plastic pollution

Blue Connections IT achieves carbon neutrality through sustainable technology

How real-world events underscore the urgency of climate disclosures

Talk from the top with Dr Jayani Chandrapala

Ferrero to acquire WK Kellogg Co for US$3.1bn

AFGC's videos busting myths about processed food

AIP flexible packaging training at Foodtech Packtech

OD200: New Compact Distance Sensor Raising the Bar in Performance and Reliability

LAPP Australia launches Harnessing Solutions division

SA small and medium-sized businesses offered a new round of energy grants

Suntory Oceania's $3bn beverage business launched in Qld

Bega Group to close peanut processing business

Konica Minolta and MiR launching two autonomous robots at CeMat